Archives of Medical Research
Volume 37, Issue 7 , Pages 866-870 , October 2006

Association of Moderate Alpha-1 Antitrypsin Deficiency with Lung Cancer in the Serbian Population

Received 10 January 2006 ,Accepted 5 May 2006.

References 

  1. Fagerhol MK, Cox DW. The Pi polymorphism: genetic, biochemical, and clinical aspects of human α1-antitrypsin. Adv Hum Genet. 1981;11:1–62
  2. Tárjan E, Magyar P, Váczi Z, Lantos Å, Vaszár L. Longitudinal lung function study in heterozygous PiMZ phenotype subjects. Eur Respir J. 1994;7:2199–2204
  3. Yang P, Wentzlaff KA, Katzmann JA, Marks RS, Allen MS, Lesnick TG, et al. Alpha-1-antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol Biomarkers Prev. 1999;8:461–465
  4. Yang P, Bamlet WR, Sun Z, Ebbert JO, Aubry MC, Taylor WR, et al. α1-Antitrypsin and neutrophil elastase imbalance and lung cancer risk. Chest. 2005;128:445–452
  5. WHO histological typing of lung tumours. 2nd ed. Geneva: World Health Organization; 1981;pp. 123–136
  6. Jelic Ivanovic Z, Spasojevic Kalimanovska V, Topic A, Spasic S, Petrovic V. Alpha-1-antitrypsin (Pi) polymorphism in Serbia: deviation of PiM subtype distribution from the Hardy-Weinberg equilibrium. Gene Geogr. 1994;8:129–135
  7. Kishimoto Y, Yamada S. Hirayama. An association between AAT phenotype and chronic liver disease. Hum Genet. 1990;84:132–136
  8. American Thoracic Society/European Respiratory Society . Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168:818–900
  9. Dietz AA, Hodges LK, Rubinstein HM. Measurement of alpha-1-antitrypsin in serum, by enzymatic assay and by immunodiffusion. In:  Cooper GR editors. Selected Method of Clinical Chemistry. Washington: American Association for Clinical Chemistry; 1979;p. 149–153
  10. de Serres FJ. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest. 2002;122:1818–1829
  11. Koblinski JE, Ahram M, Sloane BF. Unravelling the role of proteases in Cancer. Clin Chim Acta. 2000;291:113–135
  12. Sun Z, Yang P. Neutrophil elastase and alpha-1 antitrypsin: the role of imbalance in cancer development and progression; a review. Lancet Oncol. 2004;5:182–190
  13. Vlajinac H, Sipetic-Grujicic Jankovic S, Marinkovic J, Kocev N, Markovic-Denic LJ, et al. Burden of cancer in Serbia. Croat Med J. 2006;47:134–141
  14. Cancer Registry of Central Serbia—Cancer incidence and mortality in Central Serbia, 1999. Institute of Public Health of Serbia, Report No.1, Belgrade;2002.
  15. Makitaro Paakko P, Huhti E, Bloigu R, Kinnula VL. An epidemiological study of lung cancer: history and histological types in a general population in northern Finland. Eur Respir J. 1999;13:436–440
  16. Devesa SS, Shaw GL, Blot WJ. Changing patterns of lung cancer incidence by histological type. Cancer Epidemiol Biomarkers Prevent. 1991;1:29–34
  17. Yamashita J, Tashiro K, Yoneda S, Kawahara K, Shirakusa T. Local increase in polymorphonuclear leukocyte elastase is associated with tumor invasiveness in non-small cell lung cancer. Chest. 1996;109:1328–1334
  18. Yamashita J, Ogawa M, Abe M, Hayashi N, Kurusu Y, Kawahara K, et al. Tumor neutrophil elastase is closely associated with the direct extension of non-small cell lung cancer into the aorta. Chest. 1997;111:885–890
  19. Taniguchi K, Yang P, Jett J, Bass E, Meyer R, Wang Y, et al. Polymorphisms in the promoter region of the neutrophil elastase gene are associated with lung cancer development. Clin Cancer Res. 2002;8:1115–1120

PII: S0188-4409(06)00163-9

doi: 10.1016/j.arcmed.2006.05.006

Archives of Medical Research
Volume 37, Issue 7 , Pages 866-870 , October 2006

Article Tools